![]() | Only 14 pages are availabe for public view |
Abstract Conclusion: We suggested that PIR2/RNF144b can potentially be used as a biomarker for endometrial cancer for early diagnosis and for monitoring clinical progress of cancer status and efficacy of used treatment |